Empagliflozin in Patients With Cirrhosis and Ascites

Clinical trial NCT05726032 · RECRUITING

Trial details

NCT number: NCT05726032
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cirrhosis Liver Failure

Start date: 2023-09-11
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.